Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
methylphenidate hydrochloride | Capsule, hard | 20 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 25/08/2025 |
prazosin hydrochloride | Tablet, uncoated | 2.19 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 22/08/2025 |
Pancreatic extract | Capsule, enteric | 300 mg | Current | Limited Availability | Unexpected increase in consumer demand | 22/08/2025 |
magnesium chloride hexahydrate~sodium lactate~calcium chloride dihydrate~glucose~sodium chloride | Solution, irrigation | 50.8 mg/L~4.48 g/L~183 mg/L~25 g/L~5.38 g/L | Current | Limited Availability | Manufacturing | 22/08/2025 |
fampridine | Tablet, modified release | 10 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 22/08/2025 |
propranolol hydrochloride | Tablet, film coated | 40 mg | Current | Unavailable | Manufacturing | 22/08/2025 |
fluticasone propionate~salmeterol xinafoate | Inhalation, powder for | 250 microgram/actuation~72.5 microgram/actuation | Current | Limited Availability | Unexpected increase in consumer demand | 22/08/2025 |
fluticasone propionate~salmeterol xinafoate | Inhalation, pressurised | 125 microgram/actuation~36.3 microgram/actuation | Anticipated | Available | Unexpected increase in consumer demand | 22/08/2025 |
rifampicin | Capsule | 300 mg | Current | Limited Availability | Manufacturing | 22/08/2025 |
atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Current | Unavailable | Manufacturing | 22/08/2025 |
Pancreatic extract | Capsule | 420 mg | Current | Limited Availability | Unexpected increase in consumer demand | 22/08/2025 |
aciclovir | Eye Ointment | .135 g | Anticipated | Available | Manufacturing | 22/08/2025 |
spironolactone | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 22/08/2025 |
tobramycin | Inhalation, conventional | 60 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 22/08/2025 |
fentanyl | Drug delivery system, transdermal | 16.8 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 21/08/2025 |
mycophenolate mofetil | Tablet, film coated | 500 mg | Anticipated | Available | Manufacturing | 21/08/2025 |
entecavir | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 21/08/2025 |
sugammadex sodium | Injection, solution | 217.6 mg | Anticipated | Available | Manufacturing | 21/08/2025 |
rifampicin | Capsule, hard | 150 mg | Anticipated | Available | Manufacturing | 21/08/2025 |
ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 21/08/2025 |
gramicidin~dexamethasone~framycetin sulfate | Ear Drops | .05 mg/mL~.5 mg/mL~5 mg/mL | Resolved | Available | Manufacturing | 20/08/2025 |
midazolam | Injection, solution | 5 mg/mL | Current | Limited Availability | Manufacturing | 20/08/2025 |
tramadol hydrochloride | Tablet, modified release | 200 mg | Current | Limited Availability | Manufacturing | 20/08/2025 |
clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 20/08/2025 |
ciprofloxacin hydrochloride | Tablet, film coated | 555 mg | Current | Unavailable | Manufacturing | 20/08/2025 |
risperidone | Tablet, film coated | .5 mg | Current | Unavailable | Manufacturing | 20/08/2025 |
carboplatin | Injection, solution | 450 mg | Current | Limited Availability | Manufacturing | 20/08/2025 |
pemetrexed disodium | Injection, powder for | 1102.9 mg | Current | Unavailable | Manufacturing | 20/08/2025 |
mesalazine | Tablet, enteric coated | 800 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 20/08/2025 |
solifenacin succinate | Tablet | 10 mg | Current | Limited Availability | Manufacturing | 20/08/2025 |
levothyroxine sodium | Tablet | 100 microgram | Resolved | Available | Unexpected increase in consumer demand | 20/08/2025 |
levothyroxine sodium | Tablet | 75 microgram | Resolved | Available | Manufacturing | 20/08/2025 |
dexamethasone~gramicidin~framycetin sulfate | Ear Drops | .5 mg/mL~.05 mg/mL~5 mg/mL | Resolved | Available | Manufacturing | 20/08/2025 |
trandolapril | Capsule, hard | 2 mg | Current | Unavailable | Manufacturing | 20/08/2025 |
tetrabenazine | Tablet, uncoated | 25 mg | Anticipated | Available | Manufacturing | 19/08/2025 |
valaciclovir | Tablet, film coated | 500 mg | Current | Limited Availability | Manufacturing | 19/08/2025 |
benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Current | Unavailable | Manufacturing | 19/08/2025 |
pioglitazone hydrochloride | Tablet, uncoated | 33.06 mg | Resolved | Available | Manufacturing | 19/08/2025 |
sodium chloride~sodium lactate~calcium chloride dihydrate~glucose~magnesium chloride hexahydrate | Solution, irrigation | 5.38 g/L~4.48 g/L~183 mg/L~15 g/L~50.8 mg/L | Current | Limited Availability | Manufacturing | 19/08/2025 |
acetylcysteine | Injection, concentrated | 2 g | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 19/08/2025 |
paclitaxel | Injection, concentrated | 300 mg | Current | Limited Availability | Manufacturing | 19/08/2025 |
oxycodone hydrochloride | Capsule, hard | 10 mg | Resolved | Available | Commercial Changes / Commercial viability | 19/08/2025 |
betamethasone dipropionate~calcipotriol | Foam | 264 microgram/g~20.5 microgram/g | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 19/08/2025 |
clonidine hydrochloride | Tablet | 100 microgram | Current | Limited Availability | Manufacturing | 19/08/2025 |
nitisinone | Tablet | 2 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/08/2025 |
encorafenib | Capsule, hard | 50 mg | Resolved | Available | Manufacturing | 19/08/2025 |
celecoxib | Capsule, hard | 100 mg | Current | Unavailable | Manufacturing | 19/08/2025 |
mesalazine | Tablet, enteric coated | 1.6 g | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 19/08/2025 |
lurasidone hydrochloride | Tablet, film coated | 40 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/08/2025 |
lurasidone hydrochloride | Tablet, film coated | 80 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/08/2025 |
GluureaLys(ahx)hbedCC | Injection, powder for | 25 microgram | Current | Unavailable | Manufacturing | 19/08/2025 |
proguanil hydrochloride~atovaquone | Tablet, film coated | 100 mg~250 mg | Current | Limited Availability | Manufacturing | 19/08/2025 |
tetrabenazine | Tablet, uncoated | 25 mg | Anticipated | Available | Manufacturing | 19/08/2025 |
Teriparatide | Injection, solution | 250 microgram/mL | Current | Unavailable | Manufacturing | 19/08/2025 |
aripiprazole monohydrate | Injection, powder for | 416.07 mg | Current | Unavailable | Manufacturing | 19/08/2025 |
spironolactone | Tablet, film coated | 25 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 19/08/2025 |
tobramycin | Inhalation, conventional | 300 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 18/08/2025 |
mupirocin calcium | Ointment | 21.5 mg/g | Resolved | Available | Manufacturing | 18/08/2025 |
lurasidone hydrochloride | Tablet, film coated | 40 mg | Current | Unavailable | Manufacturing | 18/08/2025 |
clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 18/08/2025 |
2025年8月25日